This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Shin, J. W. et al. Permanent inactivation of Huntington's disease mutation by personalized allele-specific CRISPR/Cas9. Hum. Mol. Genet. http://dx.doi.org/10.1093/hmg/ddw286 (2016)
Rights and permissions
About this article
Cite this article
Malkki, H. Selective deactivation of Huntington disease mutant allele by CRISPR–Cas9 gene editing. Nat Rev Neurol 12, 614–615 (2016). https://doi.org/10.1038/nrneurol.2016.151
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneurol.2016.151
This article is cited by
-
Next Generation Precision Medicine: CRISPR-mediated Genome Editing for the Treatment of Neurodegenerative Disorders
Journal of Neuroimmune Pharmacology (2019)